Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs

Rating :
58/99  (View)

BSE: 526953 | NSE: VENUSREM

135.55
-5.55 (-3.93%)
23-Oct-2020 | 3:54PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  134.50
  •  142.00
  •  134.25
  •  141.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  14793
  •  20.05
  •  157.95
  •  20.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 167.23
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 462.41
  • N/A
  • 0.51

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.89%
  • 2.28%
  • 55.38%
  • FII
  • DII
  • Others
  • 0.04%
  • 0.00%
  • 6.41%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.25
  • -7.05
  • -6.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.74
  • -18.27
  • -8.51

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 18.71

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.01
  • 10.03
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.37
  • 0.21
  • 0.17

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.91
  • 6.84
  • 7.86

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
189
74
156%
83
90
-8%
97
76
27%
88
88
-1%
Expenses
173
64
171%
76
89
-15%
86
71
21%
75
72
4%
EBITDA
16
10
59%
8
2
383%
11
5
119%
13
16
-21%
EBIDTM
8%
13%
9%
2%
11%
6%
14%
18%
Other Income
2
1
149%
3
4
-26%
2
1
106%
1
3
-57%
Interest
3
6
-54%
0
0
0
4
10
-57%
5
11
-55%
Depreciation
4
8
-58%
6
8
-24%
8
8
0%
9
9
0%
PBT
2
-4
-
-5
-12
-
0
-12
-
1
0
-
Tax
0
0
0
1
-1
-
1
-1
-
0
0
-
PAT
2
-4
-
-5
-10
-
-1
-12
-
0
0
2%
PATM
1%
-6%
-6%
-12%
-1%
-15%
0%
0%
EPS
1.60
-3.31
-
-4.37
-8.47
-
-0.78
-9.54
-
0.34
0.34
0%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
457
322
372
400
418
464
542
469
410
363
314
Net Sales Growth
39%
-14%
-7%
-4%
-10%
-14%
16%
14%
13%
16%
 
Cost Of Goods Sold
257
182
205
227
239
269
300
262
226
202
182
Gross Profit
200
140
167
173
180
195
242
206
184
162
132
GP Margin
44%
43%
45%
43%
43%
42%
45%
44%
45%
44%
42%
Total Expenditure
410
289
333
349
337
375
403
349
307
273
241
Power & Fuel Cost
-
5
4
4
4
4
3
3
3
3
2
% Of Sales
-
2%
1%
1%
1%
1%
1%
1%
1%
1%
1%
Employee Cost
-
42
39
34
32
32
30
27
25
20
17
% Of Sales
-
13%
11%
9%
8%
7%
6%
6%
6%
6%
5%
Manufacturing Exp.
-
21
36
42
16
17
22
21
18
17
15
% Of Sales
-
7%
10%
11%
4%
4%
4%
4%
4%
5%
5%
General & Admin Exp.
-
12
14
13
12
16
15
12
12
12
9
% Of Sales
-
4%
4%
3%
3%
3%
3%
3%
3%
3%
3%
Selling & Distn. Exp.
-
28
35
28
34
37
33
24
23
20
15
% Of Sales
-
9%
9%
7%
8%
8%
6%
5%
6%
5%
5%
Miscellaneous Exp.
-
0
0
0
0
0
0
0
0
0
15
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
EBITDA
47
33
39
51
81
89
138
120
103
90
73
EBITDA Margin
10%
10%
11%
13%
19%
19%
26%
26%
25%
25%
23%
Other Income
8
6
2
4
2
1
0
0
0
0
0
Interest
12
25
36
36
38
41
29
25
27
19
14
Depreciation
27
34
34
40
42
46
40
33
25
19
12
PBT
-2
-21
-28
-22
4
3
69
63
51
53
46
Tax
2
-1
3
-5
2
-3
5
6
4
6
7
Tax Rate
-99%
4%
-11%
21%
52%
-95%
7%
9%
7%
12%
15%
PAT
-4
-29
-31
-17
2
5
64
57
47
46
40
PAT before Minority Interest
-4
-29
-31
-17
2
5
64
57
47
46
40
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
-1%
-9%
-8%
-4%
0%
1%
12%
12%
11%
13%
13%
PAT Growth
0%
7%
-80%
-1,105%
-67%
-92%
12%
22%
2%
17%
 
EPS
-3.21
-23.23
-24.95
-13.89
1.38
4.20
52.28
46.59
38.28
37.58
32.16

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
333
362
389
438
457
462
379
307
237
171
Share Capital
12
12
12
11
11
11
11
10
9
8
Total Reserves
320
350
376
426
445
450
364
289
224
161
Non-Current Liabilities
137
158
180
212
222
162
147
114
99
157
Secured Loans
61
87
113
135
151
115
104
75
66
92
Unsecured Loans
55
51
49
56
51
25
25
24
22
58
Long Term Provisions
5
4
4
4
4
3
3
2
2
0
Current Liabilities
264
230
197
193
163
211
191
153
125
22
Trade Payables
36
29
30
25
30
31
19
13
7
6
Other Current Liabilities
110
78
46
43
16
55
58
43
40
3
Short Term Borrowings
113
121
119
123
115
110
96
83
63
0
Short Term Provisions
5
1
2
2
2
15
19
14
14
12
Total Liabilities
733
751
765
843
841
834
718
574
461
350
Net Block
364
389
406
452
444
439
401
355
293
230
Gross Block
707
703
686
680
641
587
511
430
343
261
Accumulated Depreciation
343
314
280
227
197
148
110
75
50
31
Non Current Assets
467
490
506
566
608
562
492
404
322
230
Capital Work in Progress
65
65
66
80
78
68
48
23
15
1
Non Current Investment
0
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
38
37
33
33
86
55
43
26
14
0
Other Non Current Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
265
260
259
277
233
272
226
170
138
119
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
143
138
141
143
143
142
128
97
75
62
Sundry Debtors
38
47
47
62
63
65
47
40
36
28
Cash & Bank
3
4
4
7
4
4
6
3
3
2
Other Current Assets
82
5
0
0
24
60
44
30
24
26
Short Term Loans & Adv.
77
66
68
65
24
60
44
30
24
26
Net Current Assets
2
30
63
84
70
61
34
16
14
97
Total Assets
733
751
765
843
841
834
718
574
461
350

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
45
31
59
47
68
53
52
42
37
32
PBT
-30
-28
-22
4
3
69
63
51
53
46
Adjustment
61
66
71
56
84
37
41
30
25
12
Changes in Working Capital
14
-8
10
-13
-18
-54
-51
-39
-40
-27
Cash after chg. in Working capital
45
31
59
47
68
53
52
42
37
32
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
0
0
0
0
0
0
0
0
0
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-11
-11
-18
3
-67
-95
-104
-95
-96
-51
Net Fixed Assets
-5
-12
19
-50
-67
-94
-102
-93
-95
-52
Net Investments
0
29
0
0
0
0
0
0
-4
0
Others
-6
-28
-37
53
0
-1
-2
-1
2
1
Cash from Financing Activity
-35
-39
-44
-46
-1
40
55
53
60
20
Net Cash Inflow / Outflow
-1
-20
-4
3
-1
-2
3
0
1
1
Opening Cash & Equivalents
4
0
7
4
4
6
3
3
2
2
Closing Cash & Equivalent
3
-20
4
7
4
4
6
3
3
2

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
269
293
315
382
399
403
355
306
255
198
ROA
-4%
-4%
-2%
0%
1%
8%
9%
9%
11%
12%
ROE
-8%
-8%
-4%
0%
1%
15%
17%
18%
23%
26%
ROCE
-1%
1%
2%
5%
6%
14%
15%
16%
19%
21%
Fixed Asset Turnover
0.46
0.54
0.59
0.63
0.76
0.99
1.00
1.06
1.20
1.34
Receivable days
48
46
50
54
50
38
34
34
32
36
Inventory Days
159
137
130
125
112
91
87
77
69
62
Payable days
38
30
27
27
27
21
15
11
9
11
Cash Conversion Cycle
170
153
152
153
135
107
106
99
92
86
Total Debt/Equity
0.90
0.85
0.80
0.77
0.70
0.63
0.72
0.74
0.80
0.89
Interest Cover
0
0
0
1
1
3
4
3
4
4

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.